Acknowledging acute kidney disease following ureteroscopy and laser lithotripsy: results from a tertiary care referral center.

Acute kidney disease (AKD) Acute kidney injury (AKI) Lithotripsy Ureteroscopy

Journal

International urology and nephrology
ISSN: 1573-2584
Titre abrégé: Int Urol Nephrol
Pays: Netherlands
ID NLM: 0262521

Informations de publication

Date de publication:
15 Jul 2024
Historique:
received: 07 05 2024
accepted: 10 07 2024
medline: 15 7 2024
pubmed: 15 7 2024
entrez: 15 7 2024
Statut: aheadofprint

Résumé

Acute kidney disease (AKD) is a recently described syndrome consisting of kidney function abnormalities lasting less than 3 months. Little is known regarding AKD following ureteroscopy (URS) and laser lithotripsy. To evaluate the occurrence and evolution of AKD in stone patients treated with URS. Data from 284 patients treated with URS for urinary stones were retrospectively analyzed. According to the KDIGO 2020 criteria, AKD was defined as postoperative acute kidney injury (AKI) occurrence, estimated glomerular filtration rate (eGFR) decrease ≥ 35%, or serum creatinine (SCr) increase ≥ 50%. AKI was defined as SCr increase ≥ 0.3 mg/dL or ≥ 50%. AKD evolution was evaluated 60 days post-URS. Data were analyzed using descriptive statistics. Univariable (UVA) and multivariable (MVA) logistic regression analyses tested the association of patients' characteristics and perioperative data with the occurrence of AKD. Overall, postoperative AKD occurred in 32 (11.3%) patients. Recovery from AKD was found in 26 (82%) patients and persistent AKD occurred in 6 (18%) patients. At UVA, age at surgery (p = 0.05), baseline SCr (p = 0.02), baseline CKD category (p = 0.006), Charlson comorbidity index (p = 0.01), operative time (p = 0.04) and postoperative complications (< 0.001) were associated with AKD. At MVA, CKD category (OR 2.99, 95% CI = 1.4-6.3; p = 0.004), operative time (OR 1.01, 95% CI = 1.001-1.018; p = 0.023) and postoperative complications (OR 3.5, 95% CI = 1.46-8.49; p = 0.005) were independent predictors of AKD. AKD is a frequent complication in patients treated with URS. Moreover, AKD persists in a non-neglectable percentage of patients at medium-term follow-up. Therefore, nephrological assessment should be considered, especially in high-risk patients. Current findings should be considered for the peri-operative management of stone patients.

Sections du résumé

BACKGROUND BACKGROUND
Acute kidney disease (AKD) is a recently described syndrome consisting of kidney function abnormalities lasting less than 3 months. Little is known regarding AKD following ureteroscopy (URS) and laser lithotripsy.
OBJECTIVE OBJECTIVE
To evaluate the occurrence and evolution of AKD in stone patients treated with URS.
MATERIALS AND METHODS METHODS
Data from 284 patients treated with URS for urinary stones were retrospectively analyzed. According to the KDIGO 2020 criteria, AKD was defined as postoperative acute kidney injury (AKI) occurrence, estimated glomerular filtration rate (eGFR) decrease ≥ 35%, or serum creatinine (SCr) increase ≥ 50%. AKI was defined as SCr increase ≥ 0.3 mg/dL or ≥ 50%. AKD evolution was evaluated 60 days post-URS. Data were analyzed using descriptive statistics. Univariable (UVA) and multivariable (MVA) logistic regression analyses tested the association of patients' characteristics and perioperative data with the occurrence of AKD.
RESULTS RESULTS
Overall, postoperative AKD occurred in 32 (11.3%) patients. Recovery from AKD was found in 26 (82%) patients and persistent AKD occurred in 6 (18%) patients. At UVA, age at surgery (p = 0.05), baseline SCr (p = 0.02), baseline CKD category (p = 0.006), Charlson comorbidity index (p = 0.01), operative time (p = 0.04) and postoperative complications (< 0.001) were associated with AKD. At MVA, CKD category (OR 2.99, 95% CI = 1.4-6.3; p = 0.004), operative time (OR 1.01, 95% CI = 1.001-1.018; p = 0.023) and postoperative complications (OR 3.5, 95% CI = 1.46-8.49; p = 0.005) were independent predictors of AKD.
CONCLUSIONS CONCLUSIONS
AKD is a frequent complication in patients treated with URS. Moreover, AKD persists in a non-neglectable percentage of patients at medium-term follow-up. Therefore, nephrological assessment should be considered, especially in high-risk patients. Current findings should be considered for the peri-operative management of stone patients.

Identifiants

pubmed: 39008224
doi: 10.1007/s11255-024-04155-w
pii: 10.1007/s11255-024-04155-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer Nature B.V.

Références

Geraghty RM et al (2023) Best practice in interventional management of urolithiasis: an update from the European Association of Urology guidelines panel for urolithiasis 2022. Eur Urol Focus. https://doi.org/10.1016/j.euf.2022.06.014
doi: 10.1016/j.euf.2022.06.014 pubmed: 37277273
Ulvik Ø, Æsøy MS, Juliebø-Jones P, Gjengstø P, Beisland C (2022) Thulium fibre laser versus holmium: YAG for ureteroscopic lithotripsy: outcomes from a prospective randomised clinical trial. Eur Urol. https://doi.org/10.1016/j.eururo.2022.02.027
doi: 10.1016/j.eururo.2022.02.027 pubmed: 35637042
Castellani D et al (2023) Improving outcomes of same-sitting bilateral flexible ureteroscopy for renal stones in real-world practice—lessons learnt from global multicenter experience of 1250 patients. Eur Urol Open Sci. https://doi.org/10.1016/j.euros.2023.03.018
doi: 10.1016/j.euros.2023.03.018 pubmed: 38298767 pmcid: 10829601
Grosso AA et al (2021) Intraoperative and postoperative surgical complications after ureteroscopy, retrograde intrarenal surgery, and percutaneous nephrolithotomy: a systematic review. Minerva Urol Nephrol. https://doi.org/10.23736/S2724-6051.21.04294-4
doi: 10.23736/S2724-6051.21.04294-4 pubmed: 34156202
De Coninck V et al (2020) Complications of ureteroscopy: a complete overview. World J Urol. https://doi.org/10.1007/s00345-019-03012-1
doi: 10.1007/s00345-019-03012-1 pubmed: 32955661
Myles PS et al (2018) Restrictive versus liberal fluid therapy for major abdominal surgery. N Engl J Med. https://doi.org/10.1056/nejmoa1801601
doi: 10.1056/nejmoa1801601 pubmed: 30257158
Bravi CA et al (2019) Impact of acute kidney injury and its duration on long-term renal function after partial nephrectomy. Eur Urol. https://doi.org/10.1016/j.eururo.2019.04.040
doi: 10.1016/j.eururo.2019.04.040 pubmed: 31590938 pmcid: 7641193
Lameire NH et al. (2021) Harmonizing acute and chronic kidney disease definition and classification: report of a kidney disease: improving global outcomes (KDIGO) consensus conference. https://doi.org/10.1016/j.kint.2021.06.028 .
Kellum JA et al (2012) Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. https://doi.org/10.1038/kisup.2012.1
doi: 10.1038/kisup.2012.1
Levey AS et al (2003) National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. https://doi.org/10.7326/0003-4819-139-2-200307150-00013
doi: 10.7326/0003-4819-139-2-200307150-00013 pubmed: 12965979
Reeves T, Pietropaolo A, Gadzhiev N, Seitz C, Somani BK (2020) Role of endourological procedures (PCNL and URS) on renal function: a systematic review. Curr Urol Rep. https://doi.org/10.1007/s11934-020-00973-4
doi: 10.1007/s11934-020-00973-4 pubmed: 32318942 pmcid: 7228975
Singh P, Harris PC, Sas DJ, Lieske JC (2022) The genetics of kidney stone disease and nephrocalcinosis. Nat Rev Nephrol. https://doi.org/10.1038/s41581-021-00513-4
doi: 10.1038/s41581-021-00513-4 pubmed: 35459850 pmcid: 9379375
Geavlete P, Multescu R, Geavlete B (2014) Pushing the boundaries of ureteroscopy: current status and future perspectives. Nat Rev Urol. https://doi.org/10.1038/nrurol.2014.118
doi: 10.1038/nrurol.2014.118 pubmed: 24890883
Eredics K et al (2023) Active stone removal is a safe option for ocotogenarians and nonagenarians with nephrolithiasis. World J Urol. https://doi.org/10.1007/s00345-023-04304-3
doi: 10.1007/s00345-023-04304-3 pubmed: 36754879
Legemate JD et al (2017) Outcomes of ureterorenoscopic stone treatment in 301 patients with a solitary kidney. J Endourol. https://doi.org/10.1089/end.2017.0180
doi: 10.1089/end.2017.0180 pubmed: 28826249
Corrales M, Sierra A, Doizi S, Traxer O (2022) Risk of sepsis in retrograde intrarenal surgery: a systematic review of the literature. Eur Urol Open Sci. https://doi.org/10.1016/j.euros.2022.08.008
doi: 10.1016/j.euros.2022.08.008 pubmed: 36071820 pmcid: 9442387
Chugh S, Pietropaolo A, Montanari E, Sarica K, Somani BK (2020) Predictors of urinary infections and urosepsis after ureteroscopy for stone disease: a systematic review from EAU section of urolithiasis (EULIS). Curr Urol Rep. https://doi.org/10.1007/s11934-020-0969-2
doi: 10.1007/s11934-020-0969-2 pubmed: 32211969
Gambaro G et al (2017) The risk of chronic kidney disease associated with urolithiasis and its urological treatments: a review. J Urol. https://doi.org/10.1016/j.juro.2016.12.135
doi: 10.1016/j.juro.2016.12.135 pubmed: 28365271 pmcid: 5599330
Kellum JA, Lameire N, Aspelin P et al (2012) KDIGO clinical practice guideline for acute kidney injury 2012. Kidney Int Suppl 2:1–138
Mykoniatis I, Sarafidis P, Memmos D, Anastasiadis A, Dimitriadis G, Hatzichristou D (2021) Are endourological procedures for nephrolithiasis treatment associated with renal injury? A review of potential mechanisms and novel diagnostic indexes. Clin Kidney J. https://doi.org/10.1093/CKJ/SFAA020
doi: 10.1093/CKJ/SFAA020
Göger YE, Özkent MS, Kılınç MT, Erol E, Taşkapu HH (2023) Influencing factors of acute kidney injury following retrograde intrarenal surgery. World J Urol. https://doi.org/10.1007/s00345-023-04301-6
doi: 10.1007/s00345-023-04301-6 pubmed: 36719465
Boyer N, Eldridge J, Prowle JR, Forni LG (2022) Postoperative acute kidney injury. Clin J Am Soc Nephrol. https://doi.org/10.2215/CJN.16541221
doi: 10.2215/CJN.16541221 pubmed: 35710717 pmcid: 9528271
Sierra A, Corrales M, Kolvatzis M, Doizi S, Traxer O (2023) Real time intrarenal pressure control during flexible ureterorrenscopy using a vascular pressure wire: pilot study. J Clin Med. https://doi.org/10.3390/jcm12010147
doi: 10.3390/jcm12010147 pubmed: 38068418 pmcid: 10707177
Doizi S (2021) Intrarenal pressure: what is acceptable for flexible ureteroscopy and percutaneous nephrolithotomy? Eur Urol Focus. https://doi.org/10.1016/j.euf.2021.01.010
doi: 10.1016/j.euf.2021.01.010 pubmed: 33547026
Tokas T, Herrmann TRW, Skolarikos A, Nagele U (2019) Pressure matters: intrarenal pressures during normal and pathological conditions, and impact of increased values to renal physiology. World J Urol. https://doi.org/10.1007/s00345-018-2378-4
doi: 10.1007/s00345-018-2378-4 pubmed: 31628511
Villa L et al (2023) Understanding the role of ureteral access sheath in preventing post-operative infectious complications in stone patients treated with ureteroscopy and Ho:YAG laser lithotripsy: results from a tertiary care referral center. J Clin Med. https://doi.org/10.3390/jcm12041457
doi: 10.3390/jcm12041457 pubmed: 38202159 pmcid: 10779718
De Coninck V et al (2022) Ureteral access sheaths and its use in the future: a comprehensive update based on a literature review. J Clin Med. https://doi.org/10.3390/jcm11175128
doi: 10.3390/jcm11175128 pubmed: 36079058 pmcid: 9456781
Dean NS, Krambeck AE (2023) Endourologic procedures of the upper urinary tract and the effects on intrarenal pressure and temperature. J Endourol. https://doi.org/10.1089/end.2022.0630
doi: 10.1089/end.2022.0630 pubmed: 37786336
Kung C-W, Chou Y-H (2023) Acute kidney disease: an overview of the epidemiology, pathophysiology, and management. Kidney Res Clin Pract. https://doi.org/10.23876/j.krcp.23.001
doi: 10.23876/j.krcp.23.001 pubmed: 37165615 pmcid: 10698062
Wang H, Lambourg E, Guthrie B, Morales DR, Donnan PT, Bell S (2022) Patient outcomes following AKI and AKD: a population-based cohort study. BMC Med. https://doi.org/10.1186/s12916-022-02428-8
doi: 10.1186/s12916-022-02428-8 pubmed: 36581917 pmcid: 9801594

Auteurs

Luigi Candela (L)

Division of Experimental Oncology/Unit of Urology, Università Vita-Salute San Raffaele, URI-Urological Research Institute, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy. candela.luigi91@gmail.com.
GRC No 20, Groupe de Recherche Clinique Sur La Lithiase Urinaire, Hôpital Tenon, Sorbonne Université, Paris, France. candela.luigi91@gmail.com.

Francesco Trevisani (F)

Division of Experimental Oncology/Unit of Urology, Università Vita-Salute San Raffaele, URI-Urological Research Institute, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.

Eugenio Ventimiglia (E)

Division of Experimental Oncology/Unit of Urology, Università Vita-Salute San Raffaele, URI-Urological Research Institute, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.

Alessia D'Arma (A)

Division of Experimental Oncology/Unit of Urology, Università Vita-Salute San Raffaele, URI-Urological Research Institute, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.

Christian Corsini (C)

Division of Experimental Oncology/Unit of Urology, Università Vita-Salute San Raffaele, URI-Urological Research Institute, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.

Daniele Robesti (D)

Division of Experimental Oncology/Unit of Urology, Università Vita-Salute San Raffaele, URI-Urological Research Institute, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.

Olivier Traxer (O)

GRC No 20, Groupe de Recherche Clinique Sur La Lithiase Urinaire, Hôpital Tenon, Sorbonne Université, Paris, France.

Francesco Montorsi (F)

Division of Experimental Oncology/Unit of Urology, Università Vita-Salute San Raffaele, URI-Urological Research Institute, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.

Andrea Salonia (A)

Division of Experimental Oncology/Unit of Urology, Università Vita-Salute San Raffaele, URI-Urological Research Institute, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.

Luca Villa (L)

Division of Experimental Oncology/Unit of Urology, Università Vita-Salute San Raffaele, URI-Urological Research Institute, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.

Classifications MeSH